Related Experiment Video
Updated: Oct 16, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
An LMNA synonymous variant associated with severe dilated cardiomyopathy: Case report
Shanshan Gao1, Abigail Mumme-Monheit1, Suet Nee Chen1
1Divison of Cardiology, Cardiovascular Institute, University of Colorado, Aurora, Colorado, USA.
Insights
A novel synonymous variant in the lamin A/C (LMNA) gene was found to cause severe dilated cardiomyopathy (DCM) by reducing LMNA mRNA levels. This discovery offers new insights into the genetic causes of DCM.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is a common heart condition often linked to genetic mutations.
- Mutations in the lamin A/C (LMNA) gene are a known cause of human DCM.
- Understanding the molecular basis of DCM is crucial for diagnosis and treatment.
Observation:
- A cohort of 57 heart transplant patients with DCM was screened for LMNA gene variants.
- A novel synonymous variant, c.936G>A, was identified in the LMNA gene within a DCM family.
- Variant carriers exhibited severe familial DCM, conduction abnormalities, and elevated creatine kinase levels.
Findings:
- The LMNA c.936G>A variant was present in genomic DNA but absent in cDNA from heart tissue, indicating aberrant splicing.
- Quantitative PCR revealed significantly lower LMNA mRNA levels in patients with the variant compared to controls.
- This suggests the synonymous variant leads to reduced LMNA mRNA and potentially protein expression.
Implications:
- This study identifies a novel synonymous LMNA variant associated with DCM pathogenesis.
- The findings expand the understanding of how genetic variations in LMNA contribute to dilated cardiomyopathy.
- This research may aid in the genetic diagnosis and counseling of families affected by DCM.
Abstract:
Dilated cardiomyopathy (DCM) is one of the most common cardiac phenotypes caused by mutations of lamin A/C (LMNA) gene in humans. In our study, a cohort of 57 patients who underwent heart transplant for dilated cardiomyopathy was screened for variants in LMNA. We identified a synonymous variant c.936G>A in the last nucleotide of exon 5 of LMNA in a DCM family. Clinically, the LMNA variant carriers presented with severe familial DCM, conduction disease, and high creatine-kinase level. The LMNA c.936G>A variant is novel and has not been reported in current genetic variant databases. Sanger sequencing results showed the presence of LMNA c.936G>A variant in the genomic DNA but not in the cDNA derived from one family member's heart tissue. Real-time quantitative polymerase chain reaction showed significantly lower LMNA mRNA levels in the patient's heart compared to the controls, suggesting that the c.936G>A LMNA variant resulted in reduced mRNA and possibly lower protein expression of LMNA. These findings expand the understanding on the association between synonymous variant of LMNA and the molecular pathogenesis in DCM patients.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis I: Introduction